A. Aiuti, F. Cattaneo, S. Galimberti, U. Benninghoff, B. Cassani et al., Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency, New England Journal of Medicine, vol.360, issue.5, pp.447-58, 2009.
DOI : 10.1056/NEJMoa0805817

A. Aiuti, S. Slavin, M. Aker, F. Ficara, S. Deola et al., Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning, Science, vol.296, issue.5577, pp.2410-2413, 2002.
DOI : 10.1126/science.1070104

F. Benjelloun, A. Garrigue, C. Demerens-de-chappedelaine, P. Soulas-sprauel, M. Malassis-seris et al., Stable and Functional Lymphoid Reconstitution in Artemis-deficient Mice Following Lentiviral Artemis Gene Transfer Into Hematopoietic Stem Cells, Molecular Therapy, vol.16, issue.8, pp.1490-1499, 2008.
DOI : 10.1038/mt.2008.118
URL : https://hal.archives-ouvertes.fr/pasteur-00457775

A. E. Boitano, J. Wang, R. Romeo, L. C. Bouchez, A. E. Parker et al., Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells, Science, vol.329, issue.5997, pp.1345-1353, 2010.
DOI : 10.1126/science.1191536

K. Boztug, M. Schmidt, A. Schwarzer, P. P. Banerjee, I. A. Diez et al., Stem-Cell Gene Therapy for the Wiskott???Aldrich Syndrome, New England Journal of Medicine, vol.363, issue.20, pp.1918-1945, 2010.
DOI : 10.1056/NEJMoa1003548

F. Candotti, K. L. Shaw, L. Muul, D. Carbonaro, R. Sokolic et al., Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans, Blood, vol.120, issue.18, pp.3635-3681, 2012.
DOI : 10.1182/blood-2012-02-400937

N. Cartier, S. Hacein-bey-abina, C. C. Bartholomae, G. Veres, M. Schmidt et al., Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy, Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy, pp.818-841, 2009.
DOI : 10.1126/science.1171242

C. Cattoglio, D. Pellin, E. Rizzi, G. Maruggi, G. Corti et al., High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors, Blood, vol.116, issue.25, pp.5507-5524, 2010.
DOI : 10.1182/blood-2010-05-283523

M. Cavazzana-calvo, A. Fischer, S. Hacein-bey-abina, and A. Aiuti, Gene therapy for primary immunodeficiencies: part 1, Current Opinion in Immunology, vol.24, issue.5, pp.580-584, 2012.
DOI : 10.1016/j.coi.2012.08.008

U. P. Dave, K. Akagi, R. Tripathi, S. M. Cleveland, M. A. Thompson et al., Murine Leukemias with Retroviral Insertions at Lmo2 Are Predictive of the Leukemias Induced in SCID-X1 Patients Following Retroviral Gene Therapy, PLoS Genetics, vol.19, issue.5, p.1000491, 2009.
DOI : 10.1371/journal.pgen.1000491.s008

F. Ferrua, I. Brigida, and A. Aiuti, Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency, Current Opinion in Allergy and Clinical Immunology, vol.10, issue.6, pp.551-557, 2010.
DOI : 10.1097/ACI.0b013e32833fea85

A. Fischer, S. Hacein-bey-abina, and M. Cavazanna-calvo, Gene Therapy for Primary Immunodeficiencies, Immunology and Allergy Clinics of North America, vol.30, issue.2, pp.237-285, 2010.
DOI : 10.1016/j.iac.2010.02.002

H. B. Gaspar, S. Cooray, K. C. Gilmour, K. L. Parsley, S. Adams et al., Long-Term Persistence of a Polyclonal T Cell Repertoire After Gene Therapy for X-Linked Severe Combined Immunodeficiency, Science Translational Medicine, vol.3, issue.97, pp.97-79, 2011.
DOI : 10.1126/scitranslmed.3002715

H. B. Gaspar, S. Cooray, K. C. Gilmour, K. L. Parsley, F. Zhang et al., Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction, Science Translational Medicine, vol.3, issue.97, pp.97-80, 2011.
DOI : 10.1126/scitranslmed.3002716

A. R. Gennery, M. A. Slatter, L. Grandin, P. Taupin, A. J. Cant et al., Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: Entering a new century, do we do better?, Journal of Allergy and Clinical Immunology, vol.126, issue.3, pp.602-612, 2010.
DOI : 10.1016/j.jaci.2010.06.015

M. Grez, J. Reichenbach, J. Schwable, R. Seger, M. C. Dinauer et al., Gene Therapy of Chronic Granulomatous Disease: The Engraftment Dilemma, Molecular Therapy, vol.19, issue.1, pp.28-35, 2011.
DOI : 10.1038/mt.2010.232

S. Hacein-bey-abina, A. Garrigue, G. P. Wang, J. Soulier, A. Lim et al., Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1, Journal of Clinical Investigation, vol.118, issue.9, pp.3132-3174, 2008.
DOI : 10.1172/JCI35700DS1

S. Hacein-bey-abina, J. Hauer, A. Lim, C. Picard, G. P. Wang et al., Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency, New England Journal of Medicine, vol.363, issue.4, pp.355-64, 2010.
DOI : 10.1056/NEJMoa1000164

D. Hockemeyer, H. Wang, S. Kiani, C. S. Lai, Q. Gao et al., Genetic engineering of human pluripotent cells using TALE nucleases, Nature Biotechnology, vol.29, issue.8, pp.731-735, 2011.
DOI : 10.1038/nbt.1775

S. J. Howe, M. R. Mansour, K. Schwarzwaelder, C. Bartholomae, M. Hubank et al., Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients, Journal of Clinical Investigation, vol.118, issue.9, pp.3143-50, 2008.
DOI : 10.1172/JCI35798DS1

M. J. Hunter, L. M. Tuschong, C. J. Fowler, T. R. Bauer, . Jr et al., Gene Therapy of Canine Leukocyte Adhesion Deficiency Using Lentiviral Vectors With Human CD11b and CD18 Promoters Driving Canine CD18 Expression, Molecular Therapy, vol.19, issue.1, pp.113-134, 2011.
DOI : 10.1038/mt.2010.203

O. Kustikova, M. Brugman, and C. Baum, The genomic risk of somatic gene therapy, Seminars in Cancer Biology, vol.20, issue.4, pp.269-78, 2010.
DOI : 10.1016/j.semcancer.2010.06.003

C. Lagresle-peyrou, F. Yates, M. Malassis-seris, C. Hue, E. Morillon et al., Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity, Blood, vol.107, issue.1, pp.63-72, 2006.
DOI : 10.1182/blood-2005-05-2032

A. Lombardo, P. Genovese, C. M. Beausejour, S. Colleoni, Y. L. Lee et al., Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery, Nature Biotechnology, vol.12, issue.11, pp.1298-306, 2007.
DOI : 10.1038/nbt1353

V. C. Martins, E. Ruggiero, S. M. Schlenner, V. Madan, M. Schmidt et al., Thymus-autonomous T cell development in the absence of progenitor import, The Journal of Experimental Medicine, vol.209, issue.8, pp.1409-1426, 2012.
DOI : 10.1038/23287

O. W. Merten, S. Charrier, N. Laroudie, S. Fauchille, C. Dugue et al., Gene Therapy Application, Human Gene Therapy, vol.22, issue.3, pp.343-56, 2011.
DOI : 10.1089/hum.2010.060

U. Modlich, S. Navarro, D. Zychlinski, T. Maetzig, S. Knoess et al., Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors, Molecular Therapy, vol.17, issue.11, pp.1919-1947, 2009.
DOI : 10.1038/mt.2009.179

G. Mostoslavsky, A. J. Fabian, S. Rooney, F. W. Alt, and R. C. Mulligan, Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer, Proceedings of the National Academy of Sciences, vol.103, issue.44, pp.16406-16417, 2006.
DOI : 10.1073/pnas.0608130103

L. D. Notarangelo, A. Fischer, R. S. Geha, J. L. Casanova, H. Chapel et al., Primary immunodeficiencies: 2009 update, Journal of Allergy and Clinical Immunology, vol.124, issue.6, pp.1161-78, 2009.
DOI : 10.1016/j.jaci.2009.10.013

E. P. Papapetrou, G. Lee, N. Malani, M. Setty, I. Riviere et al., Genomic safe harbors permit high ??-globin transgene expression in thalassemia induced pluripotent stem cells, Nature Biotechnology, vol.3, issue.1, pp.73-81, 2011.
DOI : 10.1093/bioinformatics/btl646

L. Peaudecerf, S. Lemos, A. Galgano, G. Krenn, F. Vasseur et al., Thymocytes may persist and differentiate without any input from bone marrow progenitors, The Journal of Experimental Medicine, vol.19, issue.8, pp.1401-1409, 2012.
DOI : 10.1073/pnas.0913939107

F. A. Santoni, O. Hartley, and J. Luban, Deciphering the Code for Retroviral Integration Target Site Selection, PLoS Computational Biology, vol.24, issue.11, p.1001008, 2010.
DOI : 10.1371/journal.pcbi.1001008.s010

E. Szabo, S. Rampalli, R. M. Risueno, A. Schnerch, R. Mitchell et al., Direct conversion of human fibroblasts to multilineage blood progenitors, Nature, vol.98, issue.7323, pp.521-527, 2010.
DOI : 10.1038/nature09591

A. J. Thrasher, S. Hacein-bey-abina, H. B. Gaspar, S. Blanche, E. G. Davies et al., Failure of SCID-X1 gene therapy in older patients, Blood, vol.105, issue.11, pp.4255-4262, 2005.
DOI : 10.1182/blood-2004-12-4837

I. M. Verma and M. D. Weitzman, GENE THERAPY: Twenty-First Century Medicine, Annual Review of Biochemistry, vol.74, issue.1, pp.711-749, 2005.
DOI : 10.1146/annurev.biochem.74.050304.091637

S. F. Yu, T. Von-ruden, P. W. Kantoff, C. Garber, M. Seiberg et al., Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells., Proceedings of the National Academy of Sciences, vol.83, issue.10, pp.3194-3202, 1986.
DOI : 10.1073/pnas.83.10.3194

F. Zhang, L. Cong, S. Lodato, S. Kosuri, G. M. Church et al., Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription, Nature Biotechnology, vol.29, issue.2, pp.149-53, 2011.
DOI : 10.1038/nature05744